Furthermore the formation of VEGFR2/β2-adrenoceptor complexes may provide insights into their combined effects on endothelial cell proliferation and the therapeutic benefit of the β2-adrenoceptor antagonist propranolol in the treatment of infantile hemangioma. This evidence concerns the gene KDR and capillary hemangioma.